Thomas J. Smith

56.3k total citations · 19 hit papers
704 papers, 36.9k citations indexed

About

Thomas J. Smith is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Thomas J. Smith has authored 704 papers receiving a total of 36.9k indexed citations (citations by other indexed papers that have themselves been cited), including 233 papers in Public Health, Environmental and Occupational Health, 192 papers in Oncology and 100 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Thomas J. Smith's work include Palliative Care and End-of-Life Issues (179 papers), Childhood Cancer Survivors' Quality of Life (79 papers) and Cancer survivorship and care (63 papers). Thomas J. Smith is often cited by papers focused on Palliative Care and End-of-Life Issues (179 papers), Childhood Cancer Survivors' Quality of Life (79 papers) and Cancer survivorship and care (63 papers). Thomas J. Smith collaborates with scholars based in United States, United Kingdom and Canada. Thomas J. Smith's co-authors include Bruce E. Hillner, Christopher E. Desch, Mark R. Somerfield, Sarah Temin, Ronald H. Blum, James Khatcheressian, Marc S. Ernstoff, Judith A. Paice, Betty Ferrell and Patrick J. Coyne and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Thomas J. Smith

681 papers receiving 35.5k citations

Hit Papers

Interferon alfa-2b adjuvant therapy of high-risk resected... 1996 2026 2006 2016 1996 2017 2003 2012 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
    1996 1.5k citations Thomas J. Smith et al. Journal of Clinical Oncology profile →
  2. Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 1.4k citations Betty Ferrell, Sarah Temin et al. Journal of Clinical Oncology profile →
  3. American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
    2003 1.2k citations David G. Pfister, David H. Johnson et al. Journal of Clinical Oncology profile →
  4. American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care
    2012 950 citations Thomas J. Smith, Sarah Temin et al. Journal of Clinical Oncology profile →
  5. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
    2014 887 citations Judith A. Paice, Thomas J. Smith et al. Journal of Clinical Oncology profile →
  6. American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
    2009 752 citations Christopher G. Azzoli, Sherman Baker et al. Journal of Clinical Oncology profile →
  7. Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer
    2004 733 citations Thomas J. Smith et al. profile →
  8. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
    2015 695 citations Gregory A. Masters, Sarah Temin et al. Journal of Clinical Oncology profile →
  9. High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190
    2000 658 citations Thomas J. Smith et al. Journal of Clinical Oncology profile →
  10. 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
    2000 629 citations Thomas J. Smith, Mark R. Somerfield et al. Journal of Clinical Oncology profile →
  11. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
    2020 615 citations Judith A. Paice, Thomas J. Smith et al. Journal of Clinical Oncology profile →
  12. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
    2015 589 citations Thomas J. Smith et al. Journal of Clinical Oncology profile →
  13. Hospital and Physician Volume or Specialization and Outcomes in Cancer Treatment: Importance in Quality of Cancer Care
    2000 518 citations Bruce E. Hillner, Thomas J. Smith et al. Journal of Clinical Oncology profile →
  14. American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
    2009 482 citations Thomas J. Smith et al. Journal of Clinical Oncology profile →
  15. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
    2017 471 citations Sarah Temin, Sherman Baker et al. Journal of Clinical Oncology profile →
  16. American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology
    2012 458 citations Thomas J. Smith et al. Journal of Clinical Oncology profile →
  17. American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer
    2011 388 citations Jeffrey Peppercorn, Thomas J. Smith et al. Journal of Clinical Oncology profile →
  18. Management of Cancer Cachexia: ASCO Guideline
    2020 373 citations Thomas J. Smith et al. Journal of Clinical Oncology profile →
  19. Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review
    2022 124 citations Nicolas H. Hart, Thomas J. Smith et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Smith United States 88 16.1k 9.1k 7.1k 4.7k 4.2k 704 36.9k
Frank E. Speizer United States 113 7.8k 0.5× 12.8k 1.4× 8.0k 1.1× 2.8k 0.6× 3.4k 0.8× 340 64.2k
Eric J. Feuer United States 68 17.9k 1.1× 3.3k 0.4× 11.0k 1.5× 2.0k 0.4× 4.9k 1.2× 252 40.4k
Colin B. Begg United States 73 8.9k 0.5× 4.1k 0.5× 7.3k 1.0× 1.6k 0.4× 2.7k 0.7× 237 40.1k
Leslie Bernstein United States 106 17.5k 1.1× 5.9k 0.6× 5.6k 0.8× 3.5k 0.7× 7.4k 1.8× 624 41.3k
J.W.W. Coebergh Netherlands 87 16.3k 1.0× 2.9k 0.3× 6.4k 0.9× 2.3k 0.5× 4.5k 1.1× 520 30.6k
Lynn A. G. Ries United States 56 13.0k 0.8× 3.1k 0.3× 6.6k 0.9× 2.6k 0.6× 3.6k 0.9× 81 26.7k
Hans‐Olov Adami Sweden 112 16.8k 1.0× 5.7k 0.6× 9.6k 1.3× 2.6k 0.6× 6.0k 1.4× 663 48.1k
Alfred I. Neugut United States 87 12.4k 0.8× 2.8k 0.3× 6.4k 0.9× 1.7k 0.4× 4.2k 1.0× 674 31.2k
Hermann Brenner Germany 112 23.9k 1.5× 5.8k 0.6× 12.3k 1.7× 3.8k 0.8× 6.1k 1.5× 1.5k 64.7k
Richard Peto United Kingdom 108 11.2k 0.7× 11.4k 1.3× 9.7k 1.4× 2.5k 0.5× 9.2k 2.2× 300 75.8k

Countries citing papers authored by Thomas J. Smith

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Smith more than expected).

Fields of papers citing papers by Thomas J. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Smith. The network helps show where Thomas J. Smith may publish in the future.

Co-authorship network of co-authors of Thomas J. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Smith. A scholar is included among the top collaborators of Thomas J. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Smith. Thomas J. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai‐Kwon, Julia, Nicolas H. Hart, Raymond J. Chan, et al.. (2024). Delivering improved survivorship care for people affected by advanced or metastatic cancer. Acta Oncologica. 63. 939–942. 1 indexed citations
2.
Wirth, Janine, et al.. (2024). Impact of increased protein intake in older adults: a 12-week double-blind randomised controlled trial. Age and Ageing. 53(Supplement_2). ii13–ii19. 3 indexed citations
3.
Cruz‐Oliver, Dulce M., Martha Abshire Saylor, Katie E. Nelson, et al.. (2022). Hospice Family Caregiver Perceptions of Benefits and Challenges of a Telenovela Educational Intervention. Journal of Palliative Medicine. 25(6). 945–951. 7 indexed citations
4.
Smith, Thomas J., et al.. (2021). Use of Scrambler Therapy in the Treatment of Amyloidosis Neuropathic Pain. Journal of Palliative Medicine. 24(10). 1579–1581.
5.
Smith, Thomas J., et al.. (2021). Total Pain #417. Journal of Palliative Medicine. 24(7). 1100–1101. 4 indexed citations
6.
7.
Sedhom, Ramy, Arjun Gupta, & Thomas J. Smith. (2020). Short Hospice Length of Service in a Comprehensive Cancer Center. Journal of Palliative Medicine. 24(2). 257–260. 6 indexed citations
8.
Resick, Judith, Robert M. Arnold, Thomas W. LeBlanc, et al.. (2020). Primary Palliative Care for Patients with Advanced Hematologic Malignancies: A Pilot Trial of the SHARE Intervention. Journal of Palliative Medicine. 24(6). 820–829. 11 indexed citations
9.
Ferrell, Betty, Vincent Chung, Mark T. Hughes, et al.. (2020). A Palliative Care Intervention for Patients on Phase 1 Studies. Journal of Palliative Medicine. 24(6). 846–856. 29 indexed citations
10.
Alcorn, Sara R., Jacob Fiksel, Chen Hu, et al.. (2019). Pilot Assessment of the BMET Decision Support Platform: A Tool to Improve Provider Survival Estimates and Selection of Prognosis-Appropriate Treatment for Patients with Symptomatic Bone Metastases. International Journal of Radiation Oncology*Biology*Physics. 105(1). S47–S47. 5 indexed citations
11.
Ferrell, Betty, et al.. (2017). Characteristics of Participants Enrolled onto a Randomized Controlled Trial of Palliative Care for Patients on Phase I Studies. Journal of Palliative Medicine. 20(12). 1338–1344. 18 indexed citations
12.
Smith, Cardinale B., Tanyanika Phillips, & Thomas J. Smith. (2017). Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. American Society of Clinical Oncology Educational Book. 37(37). 714–723. 57 indexed citations
13.
Arnold, Robert M., Seo Young Park, Margaret Rosenzweig, et al.. (2017). A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer: Protocol and key design considerations. Contemporary Clinical Trials. 54. 98–104. 34 indexed citations
14.
Smith, Thomas J., Sarah Temin, Erin R. Alesi, et al.. (2012). American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care. Journal of Clinical Oncology. 30(8). 880–887. 950 indexed citations breakdown →
15.
Dow, Lindsay, Robin K. Matsuyama, Viswanathan Ramakrishnan, et al.. (2009). Paradoxes in Advance Care Planning: The Complex Relationship of Oncology Patients, Their Physicians, and Advance Medical Directives. Journal of Clinical Oncology. 28(2). 299–304. 131 indexed citations
16.
Azzoli, Christopher G., Sherman Baker, Sarah Temin, et al.. (2009). American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 27(36). 6251–6266. 752 indexed citations breakdown →
17.
Smith, Thomas J., Peter S. Staats, Timothy R. Deer, et al.. (2002). Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival. Journal of Clinical Oncology. 20(19). 4040–4049. 439 indexed citations
18.
Hillner, Bruce E. & Thomas J. Smith. (1996). Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.. PubMed. 23(2 Suppl 5). 25–30. 16 indexed citations
19.
Hillner, Bruce E., Thomas J. Smith, & Christopher E. Desch. (1993). Principles of Cost Effectiveness Analysis for the Assessment of Current and New Therapies. Journal of Hematotherapy. 2(4). 501–506. 3 indexed citations
20.
Smith, Thomas J., S. Katharine Hammond, Marilyn F. Hallock, & Susan Woskie. (1991). Exposure Assessment for Epidemiology: Characteristics of Exposure. Applied Occupational and Environmental Hygiene. 6(6). 441–447. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank E. Speizer Breakdown of academic impact, for papers by Eric J. Feuer Breakdown of academic impact, for papers by Colin B. Begg Breakdown of academic impact, for papers by Leslie Bernstein Breakdown of academic impact, for papers by J.W.W. Coebergh Breakdown of academic impact, for papers by Lynn A. G. Ries Breakdown of academic impact, for papers by Hans‐Olov Adami Breakdown of academic impact, for papers by Alfred I. Neugut Breakdown of academic impact, for papers by Hermann Brenner Breakdown of academic impact, for papers by Richard Peto
Rankless by CCL
2026